Items where Author is "Powe, DG"

GRUET, M., COTTON, D., COVENEY, C., BOOCOCK, D.J., WAGNER, S., KOMOROWSKI, L., REES, R.C., POCKLEY, A.G., GARNER, A.C., WALLIS, J.D., MILES, A.K. and POWE, D.G., 2020. β2-adrenergic signalling promotes cell migration by upregulating expression of the metastasis-associated molecule LYPD3. Biology, 9 (2): 39. ISSN 2079-7737

VADAKEKOLATHU, J., AL-JUBOORI, S.I.K., JOHNSON, C., SCHNEIDER, A., BUCZEK, M.E., DI BIASE, A., POCKLEY, A.G., BALL, G.R., POWE, D.G. and REGAD, T., 2018. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death & Disease, 9: 344. ISSN 2041-4889

GREEN, A.R., SORIA, D., STEPHENS, J., POWE, D.G., NOLAN, C.C., KUNKLER, I., THOMAS, J., KERR, G.R., JACK, W., CAMERON, D., PIPER, T., BALL, G.R., GARIBALDI, J.M., RAKHA, E.A., BARTLETT, J.M.S. and ELLIS, I.O., 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The Journal of Pathology: Clinical Research, 2 (1), pp. 32-40. ISSN 2056-4538

BUCZEK, M.E., MILES, A.K., GREEN, W., JOHNSON, C., BOOCOCK, D.J., POCKLEY, A.G., REES, R.C., HULMAN, G., VAN SCHALKWYK, G., PARKINSON, R., HULMAN, J., POWE, D.G. and REGAD, T., 2016. Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer. Oncogene, 35, pp. 3465-3475. ISSN 0950-9232

POWE, D.G., DHONDALAY, G.K.R., LEMETRE, C., ALLEN, T., HABASHY, H.O., ELLIS, I.O., REES, R. and BALL, G., 2014. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer. PLOS ONE, 9 (1). ISSN 1932-6203

KAFETZOPOULOU, L.E., BOOCOCK, D.J., DHONDALAY, G.K.R., POWE, D.G. and BALL, G., 2013. Biomarker identification in breast cancer: beta-adrenergic receptor signaling and pathways to therapeutic response. Computational and Structural Biotechnology Journal, 6 (7). ISSN 2001-0370

GREEN, A.R., POWE, D.G., RAKHA, E.A., SORIA, D., LEMETRE, C., NOLAN, C.C., BARROS, F.F.T., MACMILLAN, R.D., GARIBALDI, J.M., BALL, G.R. and ELLIS, I.O., 2013. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7), pp. 1886-1894. ISSN 0007-0920

LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264

SORIA, D., GARIBALDI, J.M., GREEN, A.R., POWE, D.G., NOLAN, C.C., LEMETRE, C., BALL, G. and ELLIS, I.O., 2013. A quantifier-based fuzzy classification system for breast cancer patients. Artificial Intelligence in Medicine, 58 (3), pp. 175-184. ISSN 0933-3657

ABDEL-FATAH, A., POWE, D.G., BALL, G., LOPEZ-GARCIA, M.A., HABASHY, H.O., GREEN, A.R., REIS-FILHO, J.S. and ELLIS, I.O., 2010. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. Journal of Pathology, 222 (4), pp. 388-399. ISSN 1096-9896

HABASHY, H.O., POWE, D.G., STAKA, C.M., RAKHA, E.A., BALL, G., GREEN, A.R., ALESKANDARANY, M., PAISH, E.C., MACMILLAN, R.D., NICHOLSON, R.I., ELLIS, I.O. and GEE, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806

HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., MACMILLAN, R.D., GREEN, A.R. and ELLIS, I.O., 2010. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment, 120 (3), pp. 603-612. ISSN 0167-6806

ZHANG, H., RAKHA, E.A., BALL, G.R., SPITERI, I., ALESKANDARANY, M., PAISH, E.C., POWE, D.G., MACMILLAN, R.D., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment, 121 (1), pp. 41-51. ISSN 0167-6806

LANCASHIRE, L.J., POWE, D.G., REIS-FILHO, J.S., RAKHA, E., LEMETRE, C., WEIGELT, B., ABDEL-FATAH, T.M., GREEN, A.R., MUKTA, R., BLAMEY, R., PAISH, E.C., REES, R.C., ELLIS, I.O. and BALL, G.R., 2010. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast cancer research and treatment, 120 (1), pp. 83-93. ISSN 0167-6806

ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69 (9), pp. 3802-3809. ISSN 0008-5472

WALTON, T.J., LI, G., MCCULLOCH, T.A., SETH, R., POWE, D.G., BISHOP, M.C. and REES, R.C., 2009. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue. Prostate, 69 (8), pp. 810-819. ISSN 0270-4137

HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., PAISH, C., GEE, J., NICHOLSON, R.I. and ELLIS, I.O., 2008. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer, 44 (11), pp. 1541-1551. ISSN 0959-8049

MURALI-GANESH, R., POWE, D.G., PANCHOLI, A., BALL, G.R., RAKHA, E. and ELLIS, I.O., 2007. ALCAM is an independent predictor of survival in unselected breast cancer. Ejc Supplements, 5 (3), pp. 28-29. ISSN 1359-6349

THOMPSON, N., LEIGH-BRAMWELL, S., POWE, D.G., BALL, G., RAKHA, E., WILLIAMS, J., PAISH, E.C. and ELLIS, I.O., 2006. Breast cancer profiling: A minimised panel of predictive markers for survival. Journal of Pathology, 210, p. 59. ISSN 0022-3417